Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Last data update: Jan 28, 2023. (Total: 52318 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 1836 Records)

Next

Query Trace: all[original query]>>Cancer Genomics[Category]
Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma.
Li Si Ni et al. BMC health services research 2023 23(1) 49
DNAH7 mutations benefit colorectal cancer patients receiving immune checkpoint inhibitors.
Yang Wenjuan et al. Annals of translational medicine 2023 10(24) 1335
The High Expression of p53 Is Predictive of Poor Survival Rather TP53 Mutation in Esophageal Squamous Cell Carcinoma.
Jin Yan et al. Journal of oncology 2023 20233801526
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis.
Huang Richard S P et al. Journal for immunotherapy of cancer 2023 11(1)
Optimizing molecular testing of lung cancer needle biopsy specimens: potential solutions from an interdisciplinary qualitative study.
Fintelmann Florian J et al. Respiratory research 2023 24(1) 17
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
Sargas Claudia et al. Cancers 2023 15(2)
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas.
Varadi Melinda et al. Cancer medicine 2023
Variation in Use of Lung Cancer Targeted Therapies Across State Medicaid Programs, 2020-2021.
Thomas J Roberts et al. JAMA network open 2023 6(1) e2252562
Disparities According to Genetic Ancestry in the Use of Precision Oncology Assays.
Douglas A Mata et al. The New England journal of medicine 2023 388(3) 281-283
The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer.
Fang Bangwei et al. Journal of clinical medicine 2023 12(2)
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden.
Quintanilha Julia C F et al. JAMA network open 2023 6(1) e2252244
Racial and ethnic disparities in a real-world precision oncology data registry.
Cheung Alexander T M et al. NPJ precision oncology 2023 7(1) 7
Genomic and Transcriptional Profiling of Chinese Melanoma Patients Enhanced Potentially Druggable Targets: A Multicenter Study.
Li Yue et al. Cancers 2023 15(1)
Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis.
Jiménez-Rodríguez Begoña et al. International journal of molecular sciences 2023 24(1)
Reclassification of TCGA Diffuse Glioma Profiles Linked to Transcriptomic, Epigenetic, Genomic and Clinical Data, According to the 2021 WHO CNS Tumor Classification.
Zakharova Galina et al. International journal of molecular sciences 2023 24(1)
Comprehensive analysis of the correlation between GSTM1 and tumor immunity in colon cancer.
Luo Hao-Yun et al. Journal of gastrointestinal oncology 2023 13(6) 3025-3037
Correlation between the expression of Ki67 and histopathological grade, tumor size, disease-free survival, and overall survival among breast cancer patients.
Leksono Radityo Budi et al. Breast disease 2023 41(1) 455-460
[EWSR1-SMAD3 positive fibroblastic tumor: a clinicopathological analysis].
Su H Y et al. Zhonghua bing li xue za zhi = Chinese journal of pathology 2023 52(1) 19-24
A risk stratification and prognostic prediction model for lung adenocarcinoma based on aging-related lncRNA.
Chen HuiWei et al. Scientific reports 2023 13(1) 460
Cost-effectiveness of precision molecular diagnostic tests for stage II colorectal cancer.
Chaudhari Vivek S et al. Annals of translational medicine 2023 10(23) 1260
Risk of malignancy in cytologically indeterminate thyroid nodules harboring thyroid stimulating hormone receptor mutations.
Whitmer Dorota et al. Frontiers in endocrinology 2023 131073592
The Efficacy of Molecular Analysis in the Diagnosis of Bone and Soft Tissue Sarcoma: A 15-Year Mono-Institutional Study.
Benini Stefania et al. International journal of molecular sciences 2023 24(1)
Nomogram Model for Predicting the Prognosis of High-Grade Glioma in Adults Receiving Standard Treatment: A Retrospective Cohort Study.
Du Peng et al. Journal of clinical medicine 2023 12(1)
Cervical Cancer Stage at Diagnosis and Survival among Women ≥65 Years in California.
Cooley Julianne J P et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2023 32(1) 91-97
DNA fragility at the KMT2A/MLL locus: insights from old and new technologies.
Cowell Ian G et al. Open biology 2023 13(1) 220232
African inclusion in prostate cancer genomic studies provides the first glimpses into addressing health disparities through tailored clinical care.
Hayes Vanessa M et al. Clinical and translational medicine 2023 13(1) e1142
Effects of tobacco on the DNA of smokers and non-smokers affected by OSCC: systematic review and meta-analysis.
Schuch Lauren Frenzel et al. Brazilian oral research 2023 37e008
Molecular profile of patients with myelofibrosis: a 10-year experience.
Dias Lara Faria Souza et al. Einstein (Sao Paulo, Brazil) 2023 21eAO0100
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.
Keller Rachel B et al. JCO precision oncology 2023 7e2200342
Modeling Costs and Life-Years Gained by Population-Wide Next-Generation Sequencing or Single-Gene Testing in Nonsquamous Non-Small-Cell Lung Cancer in the United States.
Lemmon Christopher A et al. JCO precision oncology 2023 7e2200294
TOP